Industry Trends

This blog post was written by Kevin Lustig, Cofounder and CEO of Scientist.com and Chris Petersen, Cofounder and CTO of Scientist.com. For years...

This blog post was written by Meaghan Loy, MS, ALAT, Senior Director of Scientific Operations and In Vivo Lead at Scientist.com. I am a lab tech at...

Over the course of this series, we have examined how supply chain fragmentation, complexity, predictive models, and distributed partnerships are...

In a landmark move toward modernizing nonclinical drug evaluation, the FDA recently issued new draft guidance that identifies specific product...

In the first three installments of this series, we explored the shifts redefining pharmaceutical development and manufacturing (PharmDev): supply...

In the first two installments of this series, we explored 2 major reasons why pharmaceutical development and manufacturing (PharmDev) is being...

In the first installment of this series, we explored the Resilience Pivot — why pharmaceutical development and manufacturing (PharmDev) is moving...

As we kick off 2026, the era of predictable, cost-optimized manufacturing has largely been replaced by one of geopolitical shifts...

This blog post was written by Biointron, a leading high-throughput recombinant antibody/protein expression and discovery service provider. Their...

In this interview, Meaghan Loy, Senior Category Director, In Vivo & GLP Services at Scientist.com, sits down with Sandra Burlock, an independent...